ArriVent BioPharma GAAP EPS of -$0.81
We haven't written up this one. Seeking Alpha News has the full story — the link below goes straight to it.
More in Finance & Markets
Ranking the "Magnificent Seven" From Most to Least Attractive, Based on Future Cash Flow
Key PointsAmid the artificial intelligence (AI) revolution, the Magnificent Seven have lifted Wall Street’s major stock indexes to new heights.
Jensen Huang affair weighs on Nvidia shares as other chip stocks rally
Nvidia bucked a broader tech rebound on Monday as investors weighed the fallout from the controversy surrounding CEO Jensen Huang. But analysts say the chipmaker's underlying business remains strong.
Jensen Huang affair weighs on Nvidia shares as other chip stocks rally
Nvidia bucked a broader tech rebound on Monday as investors weighed the fallout from the controversy surrounding CEO Jensen Huang. But analysts say the chipmaker's underlying business remains strong.
eTranzact, MTN Nigeria, lead boardroom shake-ups as 9M 2026 earnings roll in
As Nigerian Exchange (NGX)-listed companies publish their nine-month (9M) 2026 financial results, a wave of boardroom changes is also unfolding across the corporate landscape, with companies…
Treasury yields edge higher as traders await CPI inflation data
Treasurys moved higher as traders awaited October's CPI data.
The Business of Making Capital Move: Coronation Merchant Bank’s Investment Banking Year
In a market balancing expensive funding with renewed demand for capital, Coronation Merchant Bank’s 2026 experience offers a view of how Nigerian investment banking is evolving.